In helping plan the recent Winter Lung Cancer Conference held last month in Miami (stay tuned for the virtual rebroadcast) I was chatting with faculty member Dr Tom Lynch, who tipped me off that his former team at Mass General was about to publish another blockbuster mutation paper focused on a new translocation called ROS1 (a receptor tyrosine kinase of the insulin receptor family and pronounced “Ross one”). Continue reading
In helping plan the recent Winter Lung Cancer Conference held last month in Miami (stay tuned for the virtual rebroadcast) I was chatting with faculty member Dr Tom Lynch, who tipped me off that his former team at Mass General was about to publish another blockbuster mutation paper focused on a new translocation called ROS1 (a receptor tyrosine kinase of the insulin receptor family and pronounced “Ross one”). Continue reading
In helping plan the recent Winter Lung Cancer Conference held last month in Miami (stay tuned for the virtual rebroadcast) I was chatting with faculty member Dr Tom Lynch, who tipped me off that his former team at Mass General was about to publish another blockbuster mutation paper focused on a new translocation called ROS1 (a receptor tyrosine kinase of the insulin receptor family and pronounced “Ross one”). Continue reading
Dr Neil Love explains RTP's upcoming "Rounds With Investigators" recording sessions on multiple myeloma (Friday, 4/13) and lung cancer Continue reading
This unique 2-part case-based symposia series was designed to provide an array of perspectives relevant to the management of common types of cancer. Each event in the series will feature invited faculty members presenting and discussing actual patient cases from their practices. As part of these discussions, faculty members will informally review recent clinical research findings as they discuss and debate the optimal therapeutic and supportive care strategies for each patient scenario presented. No didactic presentations will be included. Continue reading
« Previous Posts